A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

计划入组 572 人 · 首次发布于 2025 年 7 月 15 日

A Study to Evaluate SAGE-217 in Participants With Essential Tremor

计划入组 34 人 · 首次发布于 2016 年 12 月 1 日

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

计划入组 180 人 · 首次发布于 2026 年 8 月 10 日

ARR-17779

ARR-18565

ARR-003

Helse Nord-Trøndelag Hf

Sweden

Follicum AB

Sweden

Cirius Therapeutics, Inc.

United States

ArriVent Advances Firmonertinib Toward Pivotal EGFR Exon 20 NSCLC Data as ADC Pipeline Progresses

Discovery of Arr-X: A Novel, Highly Efficient Rifamycin-Inactivating Enzyme Family Reveals New Antibiotic Resistance Mechanisms Across Mycobacteria

Fujirebio Launches Automated pTau 217 CSF Assay for Alzheimer's Disease Research